Ivan Pedrosa
Overview
Explore the profile of Ivan Pedrosa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
243
Citations
4720
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Su S, Yadu N, Khatri G, Khasawneh H, Pedrosa I, Yokoo T
Eur J Radiol
. 2025 Feb;
185:112001.
PMID: 39978238
Diagnosing both known and incidental liver lesions in the non-cirrhotic liver on MRI can be challenging. The radiologist can often narrow the diagnosis toward a diagnostic category using various sequences....
2.
McGrath T, Davenport M, Silverman S, Lim C, Almalki Y, Arita Y, et al.
AJR Am J Roentgenol
. 2025 Jan;
PMID: 39772585
Bosniak classification version 2019 (v2019) was a major revision to version 2005 (v2005) that defined cystic renal mass subclasses based on wall or septa features. To determine the proportion of...
3.
Gao B, Kanabur P, Campi R, Tran M, Landman J, Pedrosa I, et al.
BJU Int
. 2025 Jan;
135(3):371-379.
PMID: 39761985
No abstract available.
4.
Khene Z, Tachibana I, Bertail T, Fleury R, Bhanvadia R, Kapur P, et al.
World J Urol
. 2024 Sep;
42(1):541.
PMID: 39325194
Purpose: The management of renal cell carcinoma (RCC) relies on clinical and histopathological features for treatment decisions. Recently, radiomics, which involves the extraction and analysis of quantitative imaging features, has...
5.
Buelo C, Velikina J, Mao L, Zhao R, Yuan Q, Ghasabeh M, et al.
Magn Reson Med
. 2024 Sep;
93(1):330-340.
PMID: 39238238
Purpose: To evaluate the repeatability and reproducibility of QSM of the liver via single breath-hold chemical shift-encoded MRI at both 1.5 T and 3 T in a multicenter, multivendor study...
6.
Bezwada D, Perelli L, Lesner N, Cai L, Brooks B, Wu Z, et al.
Nature
. 2024 Aug;
633(8031):923-931.
PMID: 39143213
Most kidney cancers are metabolically dysfunctional, but how this dysfunction affects cancer progression in humans is unknown. We infused C-labelled nutrients in over 80 patients with kidney cancer during surgical...
7.
Costa D, Nguyen N, Garant A, Meng X, Courtney K, Shah R, et al.
Abdom Radiol (NY)
. 2024 Jul;
49(11):4162-4172.
PMID: 38951230
The broad range of disease aggressiveness together with imperfect screening, diagnostic, and treatment options in prostate cancer (PCa) makes medical decision-making complex. The primary goal of a multidisciplinary conference is...
8.
Simchick G, Zhao R, Yuan Q, Ghasabeh M, Ruschke S, Karampinos D, et al.
J Magn Reson Imaging
. 2024 Apr;
61(1):150-165.
PMID: 38662618
Background: Recent multicenter, multivendor MRI-based R2* vs. liver iron concentration (LIC) calibrations (i.e., MCMV calibrations) may facilitate broad clinical dissemination of R2*-based LIC quantification. However, these calibrations are based on...
9.
Prakasam G, Mishra A, Christie A, Miyata J, Carrillo D, Tcheuyap V, et al.
J Clin Invest
. 2024 Feb;
134(7).
PMID: 38386415
Translocation renal cell carcinoma (tRCC) most commonly involves an ASPSCR1-TFE3 fusion, but molecular mechanisms remain elusive and animal models are lacking. Here, we show that human ASPSCR1-TFE3 driven by Pax8-Cre...
10.
Vazquez L, Xi Y, Rasmussen R, Venzor J, Kapur P, Zhong H, et al.
J Comput Assist Tomogr
. 2024 Jan;
48(3):370-377.
PMID: 38213063
Objective: This study aimed to develop a diagnostic model to estimate the distribution of small renal mass (SRM; ≤4 cm) histologic subtypes for patients with different demographic backgrounds and clear...